Covered recipient · General Payments record
EVELYN S WHITE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2022–2024
$893.08
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $359.17 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $91.20 | 4 |
| MannKind Corporation | $69.23 | 3 |
| ABBVIE INC. | $60.70 | 3 |
| Lilly USA, LLC | $53.48 | 2 |
| Merck Sharp & Dohme Corporation | $38.98 | 2 |
| Tandem Diabetes Care, Inc. | $27.87 | 1 |
| Abbott Laboratories | $17.71 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $17.71 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125205086 | CMS |
| ABBVIE INC. | $19.95 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106331697 | CMS |
| ABBVIE INC. | $20.72 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106331699 | CMS |
| ABBVIE INC. | $20.03 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106331701 | CMS |
| Lilly USA, LLC | $24.30 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136169307 | CMS |
| Lilly USA, LLC | $29.18 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134970725 | CMS |
| Mannkind Corporation | $22.79 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145851343 | CMS |
| Mannkind Corporation | $21.31 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145851345 | CMS |
| Mannkind Corporation | $25.13 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145851347 | CMS |
| Merck Sharp & Dohme LLC | $20.76 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141659142 | CMS |
| Merck Sharp & Dohme LLC | $18.22 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141856558 | CMS |
| Novo Nordisk Inc | $18.85 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097252683 | CMS |
| Novo Nordisk Inc | $21.80 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096715835 | CMS |
| Novo Nordisk Inc | $22.42 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097625041 | CMS |
| Novo Nordisk Inc | $28.13 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096873059 | CMS |
| Tandem Diabetes Care, Inc. | $27.87 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138750795 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.